Navigation Links
Women's Testosterone Patch May Not Work
Date:3/2/2009

U.K. study also questions safety of drug Intrinsa used for sexual dysfunction

MONDAY, March 2 (HealthDay News) -- A new testosterone patch designed to boost a woman's sex drive may be ineffective, and questions remain about its long-term safety, according to the journal Drugs and Therapeutics Bulletin.

The drug Intrinsa was recently approved in the United Kingdom for treatment of women who've gone through menopause as the result of ovary and womb removal and who are receiving estrogen replacement therapy. There is some evidence that low levels of circulating testosterone may be linked to a decline in sex drive after menopause.

The patch, which is placed on the lower abdomen and delivers a daily dose of testosterone, is worn constantly and replaced twice weekly.

The journal noted, in finding that the patch may not work, that key clinical trials on testosterone patches involved highly selective groups of women. For example, the studies excluded those with various mental or physical conditions that could affect sex drive. In some trials, a hypoactive sexual desire disorder (HSDD) diagnosis was based on short, unvalidated questionnaires filled out by participants, the journal reported.

There were other problems with the studies:

  • There was a large placebo response. Significant numbers of women not treated with the patch reported improved sex drive, which suggests that low testosterone levels may not have been the problem.
  • Improvements in sex drive were small.
  • Many women were already having sex two or three times a month before they entered the trials, which raises questions about whether they really had poor sex drive in the first place.
  • The trials for Intrinsa lasted a maximum of six months, which means they didn't demonstrate the long-term safety of the patch.
  • Rates of side effects in the two key trials were around 75 percent. These included skin reactions at sites where the patches were applied, acne, excess hair, hair loss, breast pain, weight gain, insomnia , voice deepening, and migraine.

"The published evidence so far is based on highly selected women and only shows small improvements in sexual parameters and large placebo responses," according to the journal. "Also, the long-term safety of the treatment is unknown. Unwanted side effects are common and not always reversible. For all these reasons, we cannot recommend Intrinsa for use in women with sexual dysfunction."

More information

The National Women's Health Information Center has more about sexual health.



-- Robert Preidt



SOURCE: BMJ specialist journals, news release, March 3, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Womenshealthchannel Enhancements Support Pregnant Teens
2. Prostate cancer drug reduces testosterone levels in as little as 3 days
3. Study shows testosterone improves sexual well-being in post-menopausal women
4. Testosterone Patch Restores Libido in Postmenopausal Women
5. Testosterone key to disease transmission
6. AUDIO from Medialink and Solvay: Men Suffering From Symptoms of Low Testosterone Should Talk to Their Doctor
7. Studies Support Testosterone Supplements for Older Men
8. Gamma Labs to Boost Testosterone At World Series of Poker In Las Vegas
9. Men With Low Testosterone Not Receiving Treatment
10. Many men with low testosterone levels do not receive treatment
11. Testosterone Spray Improves Sexual Satisfaction in Women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Women's Testosterone Patch May Not Work
(Date:12/7/2016)... ... December 07, 2016 , ... It is vital for any ... useful, properly analyzed data. The team at Beckman Coulter has designed Kaluza, templates with ... speed' and the need to operate in a GLP (Good Laboratory Practice) fashion. , ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... They are ... are sisters and wives, brothers and fathers, from New England and around the nation. ... its stigma, and are brought together in a beautiful and compelling new photographic exhibit ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... insurance and financial consultation services to residents in the Sacramento/Folsom region, is initiating ... Chance treatment facility. , The Another Choice Another Chance treatment center in Sacramento ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, ... families throughout the Five Boroughs, is launching a charity drive to raise funds that ... the traditions and spirit of marines and Navy FMF Corpsmen. Working closely with the ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Eli Lilly and ... the neoMONARCH study of abemaciclib, a cyclin-dependent kinase (CDK) ... of reducing expression of Ki67, a biomarker of cell ... the Phase 2 trial presented during the official press ... (SABCS) evaluated abemaciclib, both alone or in combination with ...
(Date:12/7/2016)... 2016 Global Cervical Dysplasia Market: Scope ... cervical dysplasia market analyzes the current and future ... elaborate executive summary, including a market snapshot that ... The research is a combination of primary ... of our research efforts along with information collected ...
(Date:12/7/2016)... , Dec. 7, 2016 REPORT ... Market Intelligence (2011-2020)" provides market intelligence on a ... forecast (2011-2020) has been provided in the report. ... provide 1) comprehensive global market intelligence through detailed ... market dynamics, industry structure and developments, market situation, ...
Breaking Medicine Technology: